No Data
No Data
Express News | Alpha Tau Medical Publishes Pooled Analysis Of Alpha DaRT Therapy In Journal *Cancers*; Data From 4 International Trials Show Nearly 100% Overall Response Rate And 89% Complete Response Rate In Treated Lesions
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $9
Alpha Tau Medical to Spotlight Alpha DaRT at Healthcare Conference
Alpha Tau to Present at the Jefferies Global Healthcare Conference
6-K: Report of foreign private issuer (related to financial reporting)
Press Release: Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update